Evidence map›Paper›PMID 30240616›Full record

ArticleiScience2018

Isotopic Evidence for Disrupted Copper Metabolism in Amyotrophic Lateral Sclerosis.

Lucie Sauzéat, Emilien Bernard, Armand Perret-Liaudet, Isabelle Quadrio, Alain Vighetto, Pierre Krolak-Salmon, Emmanuel Broussolle, Pascal Leblanc, Vincent Balter

Open access · goldAbstract read
In one paragraph

Article in iScience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Unveiling the Origin of Copper Accumulation in Plasma with Aging.Environment & health (Washington, D.C.) · 2025
    Article
  10. Impact of aging on copper isotopic composition in the murine brain.Metallomics : integrated biometal science · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Lucie SauzéatUniversité de Lyon, ENS de Lyon, CNRS, LGL-TPE, 69007 Lyon, France.
Emilien BernardHospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, Centre de Ressources et de Compétence SLA de Lyon, Service de Neurologie C, Bron, France.
Armand Perret-LiaudetUniversité de Lyon, CNRS UMR5292, INSERM U1028, BioRan, Lyon, France; Hospices Civils de Lyon, Neurobiology Laboratory, Biochemistry and Molecular Biology Department, Lyon, France.
Isabelle QuadrioUniversité de Lyon, CNRS UMR5292, INSERM U1028, BioRan, Lyon, France; Hospices Civils de Lyon, Neurobiology Laboratory, Biochemistry and Molecular Biology Department, Lyon, France.
Alain VighettoService Neurocognition et Neuroophtalmologie, Hôpital Neurologique, 59 Boulevard Pinel, 69677 Bron Cedex, France; Centre Mémoire Ressources Recherche de Lyon, Hospices Civils de Lyon, Hôpital des Charpennes, Villeurbanne, France; Université Lyon 1, Hospices Civils de Lyon, Centre de Recherche en Neurosciences de Lyon, équipe IMPACT, Lyon, France.
Pierre Krolak-SalmonCentre Mémoire Ressources Recherche de Lyon, Hospices Civils de Lyon, Hôpital des Charpennes, Villeurbanne, France.
Emmanuel BroussolleUniversité de Lyon, Faculté de Médecine Lyon Sud Charles Mérieux, Institut des Sciences Cognitives Marc Jeannerod, CNRS, UMR 5229, Lyon, France.
Pascal LeblancInstitut NeuroMyoGène, CNRS UMR5310, INSERM U1217, Faculté de Médecine Rockefeller, Université Claude Bernard Lyon I, 8 Avenue Rockefeller, 69373 Lyon Cedex 08, France.
Vincent BalterUniversité de Lyon, ENS de Lyon, CNRS, LGL-TPE, 69007 Lyon, France. Electronic address: vincent.balter@ens-lyon.fr.
Université Claude Bernard Lyon 1 · FRHospices Civils de Lyon · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Redox-active metals are thought to be implicated in neurodegenerative diseases including amyotrophic lateral sclerosis (ALS). To address this point, we measured the concentrations of 12 elements and, for the first time, the stable isotope compositions of copper (redox-active) and zinc (redox-inactive) in human cerebrospinal fluids of 31 patients with ALS, 11 age-matched controls (CTRL), and 14 patients with Alzheimer disease. We first show that metal concentrations weakly discriminate patients with ALS from the two other groups. We then report that zinc isotopic compositions are similar in the three groups, but that patients with ALS have significantly 65copper-enriched isotopic compositions relative to CTRL and patients with AD. This result unambiguously demonstrates that copper is implicated in ALS. We suggest that this copper isotopic signature may result from abnormal protein aggregation in the brain parenchyma, and propose that isotopic analysis is a potential tool that may help unraveling the molecular mechanisms at work in ALS.

Indexed as

Clinical NeuroscienceIsotope ChemistryNeuroscienceNuclear Medicine

Identifiers

PMID30240616
PMCPMC6137708
OpenAlexW2887936129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.